FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...

With the introduction of genAI tool Elsa at the FDA in June, the technology is playing a greater role in the medical device review process.

Investing.com -- Stereotaxis (NYSE: STXS) stock surged 12% after the company received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its MAGiC Sweep catheter, the world’s first ...

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 11.2% in pre-market trading after the company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

Eli Lilly & Company (NYSE: LLY) ranks among the best non-tech stocks to buy according to billionaires. Eli Lilly & Company ...

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

Icotrokinra is designed to selectively block the IL-23 receptor, which drives inflammation in plaque psoriasis and ...

From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.

Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...